There is one undeniable fact about thrombus: the sooner it is safely dissolved and blood flow is restored, the better it is for the patient. That is why leading institutions around the world have made the EkoSonic® Endovascular System their standard of care for dissolving thrombus.

EKOS' family of ultrasonic devices gently accelerate the penetration of thrombolytic agents into thrombus, providing high levels of lysis performance and safety in a fraction of the time required by standard catheter-directed thrombolysis.

Clinical Benefits - A Preferred Alternative To Current Therapies

EKOS ultrasonic accelerated thrombolysis offers significant benefits over previously used methods of treatment for thrombus. Unlike systemic anticoagulation therapy, it actually dissolves clots, which most likely reduces the risk of post-thrombotic syndrome. Like catheter-directed thrombolysis, the simple EKOS endovascular device can be placed across the occlusive lesion in minutes, minimising cath lab time. In addition, EKOS offers significant additional clinical advantages including:

• Successfully treats thrombi in difficult to reach places, such as behind valves
• Requires significantly shorter treatment times
• Uses a lower lytic drug dosage
• Results in complete dissolution of obstructive thrombus and requires no follow up afterward with catheter-directed lytic

For more clinical benefits visit here.

Technology - How EKOS Ultrasound Accelerated Thrombolysis Unlocks The Clot